📌 Just want the highlights? Scroll down below for a TL;DR.

Alternative-Protein and Biotech Stocks Spark Massive Small-Cap Rally

NYSE | NASDAQ
October 20, 2025 | 9:00pm

Daily Market Recap: October 20, 2025

Introduction

Trading on October 20 saw a broad-based rally among small- and mid-cap names, with a handful of stocks more than doubling on heavy volume. Alternative-protein, biotech, and mining plays led the surge, while overall market sentiment was buoyed by bullish earnings updates and sector-specific catalysts.

Market Summary Table

TickerATTN PriceCurrent PriceVolumePrice Change %
YGMZ0.13910.207116,012,11848.92%
BYND0.79801.4399779,675,16880.44%
CELC59.066070.45005,167,57619.25%
CIIT0.36560.6200803,51169.58%
REPL7.43788.890067,686,20519.51%
RAPT19.767932.85002,528,51466.24%
FGI5.19986.35004,377,98422.16%
IOBT0.63160.831044,191,45231.61%
CLF14.872016.500046,570,42410.96%
KALA0.71550.93013,246,21730.00%
GSIT5.795814.330073,640,201147.28%
RANI1.33712.0600109,013,58454.10%
UHG1.46252.00503,754,11737.06%
ANRO6.009910.900011,233,66081.40%
FBGL0.40050.4980614,55424.37%
DVLT1.93052.369861,152,54422.77%
CTXR1.28871.81005,550,62340.38%
ABAT5.53106.939734,827,19125.49%
Market Rally

Market Rally by Rafelia Kurniawan

Market Trends and Patterns

Today’s session was characterized by pronounced bullish momentum in specialty sectors. Alternative-protein leader Beyond Meat (BYND) jumped over 80% on news of a debt-swap offer, while GSIT more than doubled amid reports of a potential strategic partnership. Biotechnology and clinical-stage names also outperformed: RAPT Therapeutics surged 66% after an FDA clearance and positive trial data, and AN2R Biopharma rallied 81% on licensing updates.

Volume broadly expanded, with six names trading over 30 million shares. High-volume breakouts in IOBT, DVLT and CLF underpin a rotation into beaten-down small caps, suggesting renewed speculative interest. Commodity-linked plays like CLF (steel) posted more modest gains as broader metals complex rallies cooled off by midday.

Notable Movers

• GSIT led gains with a 147% jump on 73.6 million shares, driven by partnership rumors.
• BYND advanced 80% on extreme volume, reflecting a highly debated debt-swap proposal.
• ANRO’s 81% rally followed a major licensing deal in the immuno-oncology space.
• CIIT and RAPT each climbed over 65% after financing and regulatory updates.

TL;DR

• Broad small-cap rally led by alternative-protein, biotech and mining stocks
• GSIT (+147%), ANRO (+81%), BYND (+80%) and RAPT (+66%) headline double-digit gains
• Six names traded over 30 million shares, signaling elevated speculative activity
• Biotech catalysts and debt-swap headlines drove today’s market leadership

※ The stock information provided by ATTN is for general reference only and is not intended as investment advice, solicitation, or a recommendation of any specific stocks. Information on this site may contain errors, and users are solely responsible for any decisions made based on its use.
share